Sleep Apnea Devices Market: Current Landscape and Upcoming Trends

Sleep apnea is an underrecognized sleep disorder, affecting millions of people worldwide. It is characterized by frequent interruptions in breathing during sleep. It happens when the pharyngeal airway (upper airway) gets collapsed or it does not receive signal from the brain, causing a brief pause in breathing. This breathing halt might continue from a few seconds to a minute and can happen several times during the night, disrupting the natural sleep cycle and preventing individuals from achieving restorative rest. This clinical condition impacts individuals of all ages and backgrounds, but it often goes undiagnosed or overlooked, affecting the individuals’ overall quality of life and well-being. In this article, we have highlighted details on Sleep Apnea Devices Market.

Sleep apnea can be broadly categorized into three types, obstructive sleep apnea, central sleep apnea and complex sleep apnea. Obstructive sleep apnea and central sleep apnea are the most common types of sleep apnea with similarity in symptoms, which include loud snoring, morning headache, excessive daytime sleepiness and dry mouth.

The below figure highlights some of the risk factors and symptoms associated with sleep apnea.

Sleep Apnea Risk Factors & Symptoms

The Impact of Sleep Apnea on Health

Sleep apnea poses significant risks on various dimensions of human health. The recurrent episodes of interrupted breathing, whether due to obstructive sleep apnea, central sleep apnea and complex sleep apnea can lead to a myriad of health complications if left untreated. Uncontrolled sleep apnea is associated with a higher risk of cardiovascular problems which include hypertension, heart disease and stroke. Additionally, untreated sleep apnea can contribute to several memory problems and diabetes. Medical attention and treatment are important to mitigate these potential consequences.

The below figure highlights some of the health consequences associated with sleep apnea.

Impacts of Sleep Apnea on Health

Rising Prevalence of Obstructive Sleep Apnea and Central Sleep Apnea

Nearly 1 billion individuals globally are estimated to experience mild to severe sleep apnea, yet a significant portion of this demographic remains undiagnosed. In Europe, sleep apnea has emerged as a prominent public health concern, with approximately 90 million people (22.7%) exhibiting moderate to severe obstructive sleep apnea. Similarly, in the United States, around 7% of the general population and 60% of those aged 65 and above are affected by obstructive sleep apnea. It is noteworthy that the enhanced detection and diagnosis of sleep apnea have contributed to the escalating number of reported cases of this clinical condition.

Sleep Apnea Treatment

The treatment of sleep apnea comprises a range of strategies that encompass both medical devices and pharmacological interventions. These interventions encompass techniques to ensure unobstructed airflow during sleep.

Sleep Apnea Devices Market Landscape

The following figure presents the sleep apnea devices market landscape.

Sleep Apnea Devices Market Landscape

The sleep apnea device market landscape features over 230 devices including continuous positive airway pressure machines (CPAP machine), bilevel positive airway pressure machines (BiPAP), auto-adjusting pressure machines (APAP), oral devices, implantable devices, contactless devices, adaptive servo ventilation, expiratory positive airway pressure devices, home sleep apnea test devices and polysomnography devices. Notably, the majority of the sleep apnea medical devices can be used in home care setting for the diagnosis and treatment of sleep apnea, with an aim to enhance the overall experience of end user. Some examples of obstructive sleep apnea medical devices include O2Vent Optima Mini, aura6000™, AirSense™ 11 CPAP and Bongo Rx. It is noteworthy to mention that Appscent Medical, an Israeli company, is in the process of developing a cutting-edge artificial intelligence-driven home care sleep apnea medical device for the contactless detection and sleep apnea treatment. This innovation is anticipated to significantly transform the landscape of sleep apnea treatment in the foreseeable future. Additionally, in light of recent efforts to enhance treatment convenience for this condition, nasal devices tailored for sleep apnea have emerged as particularly viable options, showcasing effectiveness in addressing sleep apnea.

Leading sleep apnea companies in sleep apnea devices market include Acurable, Advanced Brain Monitoring, Airway Management, Belun Technology, Braebon Medical, Cadwell, Desitin Pharma, Drive DeVilbiss Healthcare, Fisher Paykel, Hunan VentMed Medical Technology, Löwenstein Medical, Natus Medical, Nox Medical, Oventus Medical, Philips, React Health, ResMed, Sibelmed, Somnetics International inc, SomnoMed, Sunrise, Topson Medical, Vyaire Medical, Wellue, Whole You and ZOLL Itamar.

Sleep Apnea Devices Market: Therapeutic Devices

Majority (32%) of the therapeutic devices are oral devices, followed by AutoPAP devices (22%), BiPAP devices (19%) and CPAP machine (15%). It is worth mentioning that positive airway pressure devices (including CPAP machine, BiPAP and AutoPAP devices) are the most widely used and standard options available for sleep apnea treatment. Notable example of sleep apnea companies offering therapeutic devices include fisher paykel, natus medical and somnetics international inc. It is worth highlighting that Dormio (developed by Respo Gadgets) is the only oral device that can work on airway pressure and jaw and tongue stabilization technique.

Sleep Apnea Therapeutics Devices

Sleep Apnea Devices Market: Diagnostic Devices

Majority (89%) of the diagnostic devices are home sleep apnea testing devices (HSAT). The popularity of home sleep apnea testing devices among patients has steadily increased in the recent past. This can be primarily attributed to the fact that such devices offer a convenient and cost-effective way to monitor and diagnose sleep apnea, providing patients the comfort of their homes. Further, amongst the HSAT devices, majority (23) are non-invasive wearable devices.

Sleep Apnea by Type of Devices

Drug Therapeutics of Sleep Apnea

In addition to devices, pharmacological interventions are sometimes considered for the treatment of sleep apnea. These medications target specific physiological processes, which are related to breathing and sleep. They aim to activate airway muscle tone, reduce respiratory disturbance and stimulate neurological control centers. However, the drug pipeline is not extensive, ongoing studies continue to explore novel compounds and their potential efficacy in managing sleep apnea. As the understanding of sleep apnea deepens and medical science advances, the pharmacological arm of treatment is gaining attention for its potential to provide tailored relief to those who may not fully respond to traditional therapies.

Sleep Apnea Phase of development

Majority (73%) of the therapies intended for the treatment of sleep apnea are being evaluated in phase II clinical studies. This is followed by therapies (8%) being investigated in phase III of clinical development. Interestingly, most of the phase II therapies are being investigated for obstructive sleep apnea.

Future Perspective

The journey from diagnosis to sleep apnea treatment is a complex yet promising one. As the understanding of this condition deepens, innovative approaches are continually emerging to mitigate its impact on health and well-being. From traditional treatments like CPAP machine and oral appliances to advanced technologies, such as ASV and implant systems, the options for managing sleep apnea have expanded, offering tailored relief to individuals based on their unique needs. With a focus on enhancing sleep quality, reducing health risks and improving quality of life, the fields of sleep apnea treatment stand at the crossroad of medical advancement and personalized care. As researchers continue to unravel the intricacies of sleep apnea and explore new avenues, the future holds potential for even more effective and individualized solutions to address this widespread yet often undiagnosed condition.